Trial Profile
Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 Jan 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 25 Dec 2013 Public title from clinicalTrials.gov record added as study title.
- 25 Dec 2013 New trial record